يعرض 321 - 340 نتائج من 24,549 نتيجة بحث عن '(( significant decrease decrease ) OR ( significant ((largest decrease) OR (greater increase)) ))', وقت الاستعلام: 0.60s تنقيح النتائج
  1. 321

    Test results under the UNLCSL path. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  2. 322
  3. 323

    Test scheme. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  4. 324
  5. 325
  6. 326

    Cohesion correction coefficient. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  7. 327

    Fig 18 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  8. 328

    Fig 29 in each curve fitting results. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  9. 329
  10. 330

    Specimen packaging process. حسب Zhezhe Zhang (19704587)

    منشور في 2024
    الموضوعات:
  11. 331
  12. 332
  13. 333
  14. 334

    Evogliptin attenuates the phenotypic switch of VSMCs during CER treatment by decreasing the osteogenesis-associated genes <i>in-vitro.</i> حسب Razia Rashid Rahil (22772495)

    منشور في 2025
    "…(B, C) Summarized bar graph showed EVO significantly decreased calcium deposition and calcium content in CER treated P<sub>i</sub>-induced VSMCs. …"
  15. 335
  16. 336
  17. 337

    Table 2_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  18. 338

    Table 1_Bibliometric analysis of global research on the clinical applications of aminoglycoside antibiotics: improving efficacy and decreasing risk.docx حسب Tengxiang Zhao (20749475)

    منشور في 2025
    "…Avoiding prolonged dosing cycles and refraining from using AGs in patients with the m.1555 A > G gene variant can significantly mitigate the risk of ototoxicity. Future studies should examine the pharmacokinetic and pharmacodynamic targets of AGs and assess the efficacy and safety of administration by inhalation to improve efficacy and decrease risk.…"
  19. 339
  20. 340